H Moriwaki

783 total citations
22 papers, 664 citations indexed

About

H Moriwaki is a scholar working on Epidemiology, Hepatology and Physiology. According to data from OpenAlex, H Moriwaki has authored 22 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 9 papers in Hepatology and 5 papers in Physiology. Recurrent topics in H Moriwaki's work include Liver Disease Diagnosis and Treatment (9 papers), Liver Disease and Transplantation (7 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). H Moriwaki is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Liver Disease and Transplantation (7 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). H Moriwaki collaborates with scholars based in Japan and United States. H Moriwaki's co-authors include Takashi Yoshida, Masataka Kato, Y Muto, Kazuyuki Suzuki, Shunichi Sato, Atsushi Watanabe, A. Kato, Teiji Nakamura, S. Nishiguchi and Yasuhiro Yamada and has published in prestigious journals such as Clinical Infectious Diseases, Gut and Journal of Hepatology.

In The Last Decade

H Moriwaki

21 papers receiving 646 citations

Peers

Countries citing papers authored by H Moriwaki

Since Specialization

Citations

This map shows the geographic impact of H Moriwaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Moriwaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Moriwaki more than expected).

Fields of papers citing papers by H Moriwaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Moriwaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Moriwaki. The network helps show where H Moriwaki may publish in the future.

Co-authorship network of co-authors of H Moriwaki

This figure shows the co-authorship network connecting the top 25 collaborators of H Moriwaki. A scholar is included among the top collaborators of H Moriwaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Moriwaki. H Moriwaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Combined adenomatoid tumor and well differentiated papillary mesothelioma of the omentum 2011 ·Pathology International ·Yuichiro Hatano, Yoshinobu Hirose, Kengo Matsunaga, Yusuke Kito, Ichiro Yasuda, H Moriwaki, Shinji Osada, Kazuhiro Yoshida, Akira Hara	12
2	Synergistic effects of RXRα and PPARγ ligands to inhibit growth in human colon cancer cells—phosphorylated RXRα is a critical target for colon cancer management 2007 ·Gut ·Kenji Yamazaki, Masato Shimizu, Mitsuru Okuno, Rie Matsushima‐Nishiwaki, Nobuhiro Kanemura, (unknown), (unknown), Soichi Kojima, I. Bernard Weinstein, H Moriwaki	88
3	Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis 2006 ·Hepatology Research ·Y Muto, Shunichi Sato, Atsushi Watanabe, H Moriwaki, Kazuyuki Suzuki, A. Kato, Masataka Kato, Teiji Nakamura, (unknown), S. Nishiguchi	184
4	Liver injury induced by lipopolysaccharide is mediated by TNFR-1 but not by TNFR-2 or Fas in mice 2005 ·Hepatology Research ·(unknown), Yasuhiro Yamada, Masataka Okuno, Hiroo Ohnishi, Yosuke Osawa, Mariko Seishima, H Moriwaki	23
5	Lack of tumor necrosis factor receptor type 1 inhibits liver fibrosis induced by carbon tetrachloride in mice 2005 ·Cytokine ·(unknown), Yasuhiro Yamada, H Moriwaki, (unknown), Mariko Seishima	68
6	Metabolic disorders in patients with liver cirrhosis 2004 ·Hepatology Research ·Masataka Kato, H Moriwaki	9
7	Nocturnal energy and BCAA supplementation in patients with liver cirrhosis 2004 ·Hepatology Research ·(unknown), H Moriwaki	15
8	Interleukin-10 inhibits hepatic injury and tumor necrosis factor-α and interferon-γ mRNA expression induced by staphylococcal enterotoxin B or lipopolysaccharide in galactosamine-sensitized mice 1999 ·Journal of Hepatology ·Masahito Nagaki, (unknown), Akihiko Sugiyama, (unknown), H Moriwaki	65
9	Oral Supplementation with Branched-Chain Amino Acids Improves Survival Rate of Rats with Carbon Tetrachloride-Induced Liver Cirrhosis 1998 ·Digestive Diseases and Sciences ·Kenta Kajiwara, Masataka Okuno, Tetsuo Kobayashi, (unknown), Toshio Maki, (unknown), Hiroo Ohnishi, Yasutoshi Muto, H Moriwaki	41
10	[Acute promyelocytic leukemia accompanied by scrotal Fournier's gangrene during ATRA treatment and relapsed as external ear tumor]. 1998 ·PubMed ·Hideko Goto, Hisashi Tsurumi, Senji Kasahara, Tadashi Hara, Takafumi Yamada, (unknown), Shinobu Tanabashi, Masaaki KAMETANI, H Moriwaki	12
11	Incidence of Anaerobic Infections Among Patients with Pulmonary Diseases: Japanese Experience with Transtracheal Aspiration and Immediate Bedside Anaerobic Inoculation 1996 ·Clinical Infectious Diseases ·Tatsuo Kato, (unknown), Nobuo Murakami, H Moriwaki, (unknown), Kazue Ueno, Kunitomo Watanabe	5
12	Reduced intestinal apo A-IV mRNA levels in patients with liver cirrhosis 1995 ·International Hepatology Communications ·Mariko Seishima, Masaharu Nishimura, H Moriwaki, (unknown), Akinori Noma	2
13	Hepatitis C virus infection involved in fulminant hepatitis in Japan 1994 ·International Hepatology Communications ·Hiroo Ohnishi, Y Muto, Toshiyuki Sakai, (unknown), (unknown), H Moriwaki	1
14	The clearance rate of retinyl ester from plasma distinguishes patients with idiopathic portal hypertension from those with liver cirrhosis 1993 ·International Hepatology Communications ·Takashi Shimomura, H Moriwaki, Eiichi Tomita, Masataka Okuno, (unknown), Hirofumi Ohnishi, (unknown)	1
15	Non-invasive assessment of acute effects of cigarette smoking on cerebral circulation. 1993 ·PubMed ·Kazufumi Kimura, (unknown), Nobuo Handa, Kazuo Hashikawa, H Moriwaki	4
16	[Determination and clinical significance of human hepatocyte growth factor in serum]. 1992 ·PubMed ·Masao Takemura, (unknown), Shôji Nakamura, Masaaki Okuno, M Seishima, Akio Noma, (unknown), (unknown), Hiroshi Sugiyama, H Moriwaki	4
17	[Barotraumatic cerebral air embolism following scuba diving]. 1990 ·PubMed ·Naoyuki Nakao, H Moriwaki, (unknown)	7
18	Three cases of severe acetaminophen overdose. 1989 ·Kanzo ·Makoto Shimazaki, Junichi Sugihara, Nobuo Murakami, (unknown), (unknown), (unknown), (unknown), H Moriwaki, Eiichi Tomita, Yasutoshi Muto, (unknown), (unknown), (unknown), Yoshiyata TAKAHASHI	2
19	Effect of long-term oral supplementation with branched-chain amino acid granules on the prognosis of liver cirrhosis 1989 ·Gastroenterologia Japonica ·Takashi Yoshida, (unknown), H Moriwaki, (unknown)	115
20	Tuberous sclerosis with an atypical radiological skull change 1985 ·Neurosurgery ·Tetsuya Terada, Eiichi Nakai, H Moriwaki, Shinya Hayashi, Norihiko Komai	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact